Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Osteogenic Sarcoma Recurrent”

196 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 196 results

Early research (Phase 1)Study completedNCT00036959
What this trial is testing

ABT-751 in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more
National Institutes of Health Clinical Center (CC) 90
Testing effectiveness (Phase 2)Study completedNCT00004078
What this trial is testing

Irinotecan in Treating Children With Refractory Solid Tumors

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus TumorChildhood Craniopharyngioma+18 more
Children's Oncology Group 181
Testing effectiveness (Phase 2)Study completedNCT01833520
What this trial is testing

Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma

Who this might be right for
Sarcoma
M.D. Anderson Cancer Center 18
Not applicableStudy completedNCT01586104
What this trial is testing

Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases

Who this might be right for
Adult RhabdomyosarcomaLung MetastasesMetastatic Ewing Sarcoma+9 more
Ann & Robert H Lurie Children's Hospital of Chicago 20
Testing effectiveness (Phase 2)Ended earlyNCT02718482
What this trial is testing

Phase II Trial for the Treatment of Relapsed Osteosarcoma

Who this might be right for
OSTEOSARCOMA
Italian Sarcoma Group 7
Early research (Phase 1)Study completedNCT00101270
What this trial is testing

Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas

Who this might be right for
Childhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Diffuse Large Cell Lymphoma+26 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)WithdrawnNCT01174537
What this trial is testing

New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma

Who this might be right for
GlioblastomaSarcomaNeuroblastoma
Hadassah Medical Organization
Testing effectiveness (Phase 2)Active Not RecruitingNCT02243605
What this trial is testing

Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma

Who this might be right for
Metastatic Ewing SarcomaMetastatic OsteosarcomaRecurrent Ewing Sarcoma+7 more
National Cancer Institute (NCI) 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT03598595
What this trial is testing

Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma

Who this might be right for
Recurrent OsteosarcomaRefractory Osteosarcoma
M.D. Anderson Cancer Center 31
Testing effectiveness (Phase 2)Study completedNCT00572130
What this trial is testing

Phase II Study of Intravenous Rexin-G in Osteosarcoma

Who this might be right for
Osteosarcoma
Epeius Biotechnologies 22
Early research (Phase 1)Study completedNCT00020267
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Lung CancerAdult Soft Tissue SarcomaColorectal Cancer+8 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00041236
What this trial is testing

Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 39
Early research (Phase 1)Active Not RecruitingNCT03635632
What this trial is testing

C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)

Who this might be right for
Relapsed NeuroblastomaRefractory NeuroblastomaRelapsed Osteosarcoma+4 more
Baylor College of Medicine 94
Early research (Phase 1)Study completedNCT00003750
What this trial is testing

Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors

Who this might be right for
Melanoma (Skin)NeuroblastomaSarcoma+1 more
Children's Oncology Group 28
Testing effectiveness (Phase 2)Study completedNCT03526250
What this trial is testing

Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Ewing Sarcoma+29 more
National Cancer Institute (NCI) 23
Early research (Phase 1)Study completedNCT00077454
What this trial is testing

Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Previously Treated Childhood RhabdomyosarcomaRecurrent Childhood Brain TumorRecurrent Childhood Cerebellar Astrocytoma+9 more
National Cancer Institute (NCI) 95
Testing effectiveness (Phase 2)Study completedNCT03245450
What this trial is testing

Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors

Who this might be right for
Refractory or Recurrent Solid TumorsRhabdomyosarcomaNon-Rhabdomyosarcoma Soft Tissue Sarcoma+1 more
Eisai Inc. 40
Early research (Phase 1)Looking for participantsNCT06340204
What this trial is testing

Weekly Irinotecan Liposomes in Recurrent or Refractory Ewing Sarcoma

Who this might be right for
Ewing Sarcoma
Peking University People's Hospital 44
Early research (Phase 1)Active Not RecruitingNCT03618381
What this trial is testing

EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

Who this might be right for
Pediatric Solid TumorGerm Cell TumorRetinoblastoma+13 more
Seattle Children's Hospital 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT04668300
What this trial is testing

Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma

Who this might be right for
Metastatic AngiosarcomaMetastatic Dedifferentiated LiposarcomaMetastatic Osteosarcoma+5 more
M.D. Anderson Cancer Center 75
Load More Results